FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026277675> ?p ?o ?g. }

• W2026277675 endingPage "034" @default.
• W2026277675 startingPage "029" @default.
• W2026277675 abstract "With increased utilization of platelet-rich plasma (PRP), it is important for clinicians to understand the United States, the Food and Drug Administration (FDA) regulatory role and stance on PRP. Blood products such as PRP fall under the prevue of FDA's Center for Biologics Evaluation and Research (CBER). CBER is responsible for regulating human cells, tissues, and cellular and tissue-based products. The regulatory process for these products is described in the FDA's 21 CFR 1271 of the Code of Regulations. Under these regulations, certain products including blood products such as PRP are exempt and therefore do not follow the FDA's traditional regulatory pathway that includes animal studies and clinical trials. The 510(k) application is the pathway used to bring PRP preparation systems to the market. The 510(k) application allows devices that are “substantially equivalent” to a currently marketed device to come to the market. There are numerous PRP preparation systems on the market today with FDA clearance; however, nearly all of these systems have 510(k) clearance for producing platelet-rich preparations intended to be used to mix with bone graft materials to enhance bone graft handling properties in orthopedic practices. The use of PRP outside this setting, for example, an office injection, would be considered “off label.” Clinicians are free to use a product off-label as long as certain responsibilities are met. Per CBER, when the intent is the practice of medicine, clinicians “have the responsibility to be well informed about the product, to base its use on firm scientific rationale and on sound medical evidence, and to maintain records of the product's use and effects.” Finally, despite PRP being exempted, the language in 21 CFR 1271 has caused some recent concern over activated PRP; however to date, the FDA has not attempted to regulate activated PRP. Clinicians using activated PRP should be mindful of these concerns and continued to stay informed." @default.
• W2026277675 created "2016-06-24" @default.
• W2026277675 creator A5011956176 @default.
• W2026277675 creator A5032913544 @default.
• W2026277675 creator A5037043161 @default.
• W2026277675 creator A5042389009 @default.
• W2026277675 creator A5056969401 @default.
• W2026277675 creator A5069549507 @default.
• W2026277675 creator A5072380979 @default.
• W2026277675 creator A5080975334 @default.
• W2026277675 date "2014-09-30" @default.
• W2026277675 modified "2023-09-29" @default.
• W2026277675 title "US Definitions, Current Use, and FDA Stance on Use of Platelet-Rich Plasma in Sports Medicine" @default.
• W2026277675 cites W1481956539 @default.
• W2026277675 cites W1977317520 @default.
• W2026277675 cites W1999704943 @default.
• W2026277675 cites W2033568328 @default.
• W2026277675 cites W2107641904 @default.
• W2026277675 cites W2110231121 @default.
• W2026277675 cites W2117035954 @default.
• W2026277675 cites W2123166289 @default.
• W2026277675 cites W2129903568 @default.
• W2026277675 cites W2143110947 @default.
• W2026277675 cites W2145055121 @default.
• W2026277675 cites W2167432895 @default.
• W2026277675 cites W2168945706 @default.
• W2026277675 cites W2171657540 @default.
• W2026277675 cites W2324213260 @default.
• W2026277675 doi "https://doi.org/10.1055/s-0034-1390030" @default.
• W2026277675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25268794" @default.
• W2026277675 hasPublicationYear "2014" @default.
• W2026277675 type Work @default.
• W2026277675 sameAs 2026277675 @default.
• W2026277675 citedByCount "99" @default.
• W2026277675 countsByYear W20262776752015 @default.
• W2026277675 countsByYear W20262776752016 @default.
• W2026277675 countsByYear W20262776752017 @default.
• W2026277675 countsByYear W20262776752018 @default.
• W2026277675 countsByYear W20262776752019 @default.
• W2026277675 countsByYear W20262776752020 @default.
• W2026277675 countsByYear W20262776752021 @default.
• W2026277675 countsByYear W20262776752022 @default.
• W2026277675 countsByYear W20262776752023 @default.
• W2026277675 crossrefType "journal-article" @default.
• W2026277675 hasAuthorship W2026277675A5011956176 @default.
• W2026277675 hasAuthorship W2026277675A5032913544 @default.
• W2026277675 hasAuthorship W2026277675A5037043161 @default.
• W2026277675 hasAuthorship W2026277675A5042389009 @default.
• W2026277675 hasAuthorship W2026277675A5056969401 @default.
• W2026277675 hasAuthorship W2026277675A5069549507 @default.
• W2026277675 hasAuthorship W2026277675A5072380979 @default.
• W2026277675 hasAuthorship W2026277675A5080975334 @default.
• W2026277675 hasBestOaLocation W20262776751 @default.
• W2026277675 hasConcept C126322002 @default.
• W2026277675 hasConcept C142724271 @default.
• W2026277675 hasConcept C177713679 @default.
• W2026277675 hasConcept C188313352 @default.
• W2026277675 hasConcept C2780076745 @default.
• W2026277675 hasConcept C3018890749 @default.
• W2026277675 hasConcept C535046627 @default.
• W2026277675 hasConcept C71924100 @default.
• W2026277675 hasConcept C89560881 @default.
• W2026277675 hasConcept C98274493 @default.
• W2026277675 hasConceptScore W2026277675C126322002 @default.
• W2026277675 hasConceptScore W2026277675C142724271 @default.
• W2026277675 hasConceptScore W2026277675C177713679 @default.
• W2026277675 hasConceptScore W2026277675C188313352 @default.
• W2026277675 hasConceptScore W2026277675C2780076745 @default.
• W2026277675 hasConceptScore W2026277675C3018890749 @default.
• W2026277675 hasConceptScore W2026277675C535046627 @default.
• W2026277675 hasConceptScore W2026277675C71924100 @default.
• W2026277675 hasConceptScore W2026277675C89560881 @default.
• W2026277675 hasConceptScore W2026277675C98274493 @default.
• W2026277675 hasIssue "01" @default.
• W2026277675 hasLocation W20262776751 @default.
• W2026277675 hasLocation W20262776752 @default.
• W2026277675 hasOpenAccess W2026277675 @default.
• W2026277675 hasPrimaryLocation W20262776751 @default.
• W2026277675 hasRelatedWork W1575722488 @default.
• W2026277675 hasRelatedWork W1986789756 @default.
• W2026277675 hasRelatedWork W2009722415 @default.
• W2026277675 hasRelatedWork W2018066623 @default.
• W2026277675 hasRelatedWork W2024857401 @default.
• W2026277675 hasRelatedWork W2088991689 @default.
• W2026277675 hasRelatedWork W3154633948 @default.
• W2026277675 hasRelatedWork W3194210683 @default.
• W2026277675 hasRelatedWork W395437453 @default.
• W2026277675 hasRelatedWork W4254162454 @default.
• W2026277675 hasVolume "28" @default.
• W2026277675 isParatext "false" @default.
• W2026277675 isRetracted "false" @default.
• W2026277675 magId "2026277675" @default.
• W2026277675 workType "article" @default.